PetMed Express (PETS) vs. Its Rivals Head-To-Head Analysis

PetMed Express (NASDAQ:PETS) is one of 67 public companies in the “INTERNET COMMERCE” industry, but how does it weigh in compared to its competitors? We will compare PetMed Express to related companies based on the strength of its valuation, institutional ownership, analyst recommendations, earnings, dividends, risk and profitability.

Profitability

This table compares PetMed Express and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PetMed Express	0.14%	0.37%	0.23%
PetMed Express Competitors	-13.16%	-48.48%	-5.20%

Analyst Recommendations

This is a summary of recent ratings and target prices for PetMed Express and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetMed Express	1	1	0	0	1.50
PetMed Express Competitors	589	3698	7973	249	2.63

PetMed Express currently has a consensus price target of $3.35, indicating a potential upside of 8.06%. As a group, “INTERNET COMMERCE” companies have a potential upside of 1.49%. Given PetMed Express’ higher probable upside, equities analysts clearly believe PetMed Express is more favorable than its competitors.

Institutional & Insider Ownership

73.3% of PetMed Express shares are held by institutional investors. Comparatively, 50.1% of shares of all “INTERNET COMMERCE” companies are held by institutional investors. 1.1% of PetMed Express shares are held by company insiders. Comparatively, 19.0% of shares of all “INTERNET COMMERCE” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares PetMed Express and its competitors gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
PetMed Express	$281.06 million	-$7.46 million	310.00
PetMed Express Competitors	$56.21 billion	$2.17 billion	31.50

PetMed Express’ competitors have higher revenue and earnings than PetMed Express. PetMed Express is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Risk & Volatility

PetMed Express has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Comparatively, PetMed Express’ competitors have a beta of 1.55, meaning that their average stock price is 55% more volatile than the S&P 500.

Summary

PetMed Express competitors beat PetMed Express on 7 of the 13 factors compared.

About PetMed Express

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.